Aurora Cannabis (ACB) Beginning Cash Balance (2017 - 2024)
Aurora Cannabis (ACB) posted quarterly Beginning Cash Balance of $60.8 million for Q4 2024, down 35.8% year-on-year from $94.7 million in Q1 2024, and down 28.19% on a QoQ basis from $84.7 million in Q3 2024.
Aurora Cannabis (ACB) Beginning Cash Balance (2017 - 2024) Analysis & Trends
Aurora Cannabis (ACB) has reported Beginning Cash Balance for 8 consecutive years, with $60.8 million the latest figure, recorded in Q4 2024.
- Quarterly Beginning Cash Balance fell 35.8% year-over-year to $60.8 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $323.1 million (down 62.64% YoY) and the FY2023 annual result came in at $174.9 million, down 47.49% from the prior year.
- Beginning Cash Balance declined to $60.8 million in Q4 2024 per ACB's latest filing, from $84.7 million in the prior quarter.
- Over the last five years, Beginning Cash Balance for ACB reached as high as $347.8 million in Q3 2021 and fell as low as -$13.0 million in Q4 2021.
- A 5-year average of $171.5 million and a median of $117.7 million in 2023 frame the typical range for Beginning Cash Balance.
- Annual changes were most pronounced in 2022 — Beginning Cash Balance soared 2541.62% — and 2023, when it tumbled 70.1%.
- Year by year, Beginning Cash Balance stood at $121.7 million in 2020, then plunged by 110.66% to -$13.0 million in 2021, then jumped by 2541.62% to $316.7 million in 2022, then slumped by 70.1% to $94.7 million in 2023, then sank by 35.8% to $60.8 million in 2024.
- According to Business Quant data, Beginning Cash Balance over the past three periods registered $60.8 million, $84.7 million, and $82.9 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 60.79 Mn |
| Dec 31, 2024 | 60.79 Mn |
| Sep 30, 2024 | 84.66 Mn |
| Sep 30, 2024 | 84.66 Mn |
| Jun 30, 2024 | 82.94 Mn |
| Jun 30, 2024 | 82.94 Mn |
| Dec 31, 2023 | 94.69 Mn |
| Dec 31, 2023 | 94.69 Mn |
| Sep 30, 2023 | 117.75 Mn |
| Sep 30, 2023 | 117.75 Mn |
| Dec 31, 2022 | 316.70 Mn |
| Dec 31, 2022 | 316.70 Mn |
| Sep 30, 2022 | 335.69 Mn |
| Sep 30, 2022 | 335.69 Mn |
| Jun 30, 2022 | 337.18 Mn |
| Jun 30, 2022 | 337.18 Mn |
| Dec 31, 2021 | -12.97 Mn |
| Dec 31, 2021 | -12.97 Mn |
| Sep 30, 2021 | 347.80 Mn |
| Sep 30, 2021 | 347.80 Mn |